Warren Buffett is BUYING! Pharmaceuticals in, banks out? (Berkshire Q3 13F)

TL;DR

Warren Buffett shifted from massive selling in Q2 to net buying in Q3, with notable moves including reducing exposure to US banks, trimming Apple, and investing in pharmaceutical companies.

Transcript

so last quarter warren buffett certainly uh shocked a lot of us with the sheer amount of selling that he did from his portfolio i remember he sold out of seven positions entirely which is very unlike warren buffett four of those positions were the big u.s airlines you can remember how big of a story that was at the time and i remember listening or ... Read More

Key Insights

• 🪐 Warren Buffett transitioned from massive selling in Q2 to net buying in Q3, showcasing a strategic shift in investment approach.
• 👶 Berkshire Hathaway increased its portfolio value to $228.9 billion in Q3, with additions to four positions and investments in six new stocks.
• 🏦 Buffett reduced exposure to US banks while trimming his stake in Apple and investing in pharmaceutical companies like Merck, ABV, Bristol-Myers Squibb, and Pfizer.
• 🥹 Notable positions include a significant decrease in Apple holdings, trimming its stake by 3.7% to $109.4 billion.
• 🖐️ Buffett's investments in pharmaceutical companies like Merck, ABV, Bristol-Myers Squibb, and Pfizer showcased a diversified play on the industry.
• 👶 Berkshire Hathaway's new buys in Q3 included positions in T-Mobile and Snowflake, while completely selling out of Costco.
• 🌎 Warren Buffett's continued reduction in exposure to US banks, except for Bank of America, indicates a strategic shift in sector preference.

Questions & Answers

Q: Why did Warren Buffett shock investors with massive selling in Q2?

Warren Buffett significantly reduced his portfolio by selling out of seven positions, including four major US airlines, in Q2, causing surprise among investors and analysts.

Q: What was the major shift in Warren Buffett's investing strategy in Q3?

Warren Buffett transitioned from selling to net buying in Q3, allocating $17.6 billion into equity securities after selling $12 billion worth of equities, showcasing a significant change in strategy.

Q: What were the key highlights of Warren Buffett's Q3 investments?

In Q3, Buffett reduced exposure to US banks, trimmed his Apple stake, and invested in pharmaceutical companies like Merck, ABV, Bristol-Myers Squibb, and Pfizer, along with buying into T-Mobile, Snowflake, and selling out of Costco.

Q: How did Warren Buffett's portfolio change in Q3 compared to Q2?

In Q3, Berkshire Hathaway's portfolio increased in value to $228.9 billion, with additions to four positions, investments in six new stocks, reductions in nine, and complete sale from one position, showcasing a shift towards more buying than selling.

Summary & Key Takeaways

• Warren Buffett shocked investors by selling significantly in Q2 but shifted to net buying in Q3.

• Buffett reduced exposure to US banks while trimming Apple and investing in pharmaceutical companies.

• Berkshire Hathaway's Q3 portfolio added new positions in pharmaceuticals and telecommunications while selling out of Costco.